Lin BioScience, Inc. (TPEX:6696)
Taiwan · Delayed Price · Currency is TWD 396.50
-5.50 (-1.37%)
May 15, 2026, 2:00 PM CST
Lin BioScience Market Cap
Lin BioScience has a market cap or net worth of 33.26 billion as of May 15, 2026. Its market cap has increased by 248.27% in one year.
Market Cap
33.26B
Enterprise Value
31.39B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
396.50
Market Cap Chart
Since October 8, 2018, Lin BioScience's market cap has increased from 2.92B to 33.26B, an increase of 1,040.41%. That is a compound annual growth rate of 37.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 33.26B | 1.26% |
| Dec 31, 2025 | 32.84B | 203.76% |
| Dec 31, 2024 | 10.81B | 20.85% |
| Dec 29, 2023 | 8.95B | -28.90% |
| Dec 30, 2022 | 12.58B | -1.94% |
| Dec 30, 2021 | 12.83B | 83.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pell Bio-Med Technology | 46.86B |
| Oneness Biotech | 24.92B |
| Lumosa Therapeutics | 21.44B |
| Sunmax Biotechnology | 20.75B |
| Medigen Vaccine Biologics | 16.11B |
| AP Biosciences | 15.19B |
| CHO Pharma | 14.94B |
| TaiMed Biologics | 14.67B |